ESR1 and breast cancer: Establishing whether such mechanisms is important for determining the changes in BP values in women with aging, during the menstrual cycle, or during long-term treatment with estrogen-receptor modulators, which are being prescribed to a multitude of women with estrogen-receptor positive breast cancer, is a key question to be addressed with specific research in the future decade.